Stem Cells Rehabilitate Diabetic Neuropathy

Authors

  • Dr. Hazim Abdul Rahman Alhiti Iraqi ministry of health Author
  • Dr. Ahmad Mansour Hamad Department of Surgery, Mansour university college, Higher Institute of Health, Al Anbar Directorate of Health, Iraqi ministry of health, Iraq Author

DOI:

https://doi.org/10.61856/7c8pf105

Keywords:

Stem Cells, repair, Iraqi, Diabetic Foot, neuropathy

Abstract

To report the effectiveness of stem cell treatment in diabetic neuropathy. This study recruited 83 Iraqi females from 45 to 73 years old who had NIDDM between August 31, 2020 and June 30, 2023. All of them had a "Diabetic neuropathy symptom score (DNS)" (grade 3–4) and a "Diabetic foot sensory neuropathy score" (grade 1-2). They all had HbA1c (10-13%) from 7 to 10 years. The patient/family provided informed permission when they visited the "Al Zahrawy Center for Stem Cells in Baghdad". For four treatment sessions (once every three weeks), Hamad dispersed stem cells around the tibial and deep peroneal nerves. Among 83 Iraqi females, 49 (59.1%) had a grade 4 "Diabetic neuropathy symptom score" upon presentation, which decreased to 24.2% in 20 females after three months of medication. Their "Diabetic foot sensory neuropathy (DNS)" was (54.3%) in 45 females at presentation and decreased to (21.8%) in 18 females after three months of treatment. The satisfaction rate for therapy was 74.6% for the "Diabetic neuropathy symptom score" and 78.3% for "Diabetic foot sensory neuropathy (DNS)". Stem cell therapy is a good treatment option for diabetic neuropathy. The researchers supported it and suggested a greater sample size in other places.

Author Biographies

  • Dr. Hazim Abdul Rahman Alhiti, Iraqi ministry of health

    Dr. Hazim Abdul Rahman Alhiti

    General Surgeon Specialist M.D

    Al-Ramadi Teaching Hospital

    Chief of Breast Clinic (Hit General Hospital)

    Chief of Cancer Clinic (Hit General Hospital)

    Academic lecturer in al Mansour university college-Baghdad

    Academic lecturer in college of medicine-university of Fallujah

    Academic lecturer in college of medicine-Al Iraqia University

    Academic lecturer (Electronic learning)- Tikrit University

    Academic external examiner-college of medicine- University of Baghdad

    Academic external examiner-college of medicine- University of Ibn Sina

    Academic external examiner- college of medicine-University of Al-Qadisiyah

    Head of emergency department, Higher Institute of Health, Al Anbar Directorate of Health

    009647821490455

    hazim.extpht@muc.edu.iq

    hazim4436@gmail.com

    https://orcid.org/0000-0003-0000-8267

  • Dr. Ahmad Mansour Hamad, Department of Surgery, Mansour university college, Higher Institute of Health, Al Anbar Directorate of Health, Iraqi ministry of health, Iraq
    iijas

References

Al-Massri, K. (2020). Mesenchymal stem cells in chemotherapy-induced peripheral neuropathy: A new challenging approach that requires further investigations. Journal of Tissue Engineering and Regenerative Medicine, 14(1), 108-122. doi: https://doi.org/10.1002/term.2972

Sloan, G. (2021). Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol, 17(7), 400-420. doi: https://doi.org/10.1038/s41574-021-00496-z

Hamad, A.M,, & Alhiti, H.A. R. (2022). Non-Obstructive Azoospermia Aided by Autologous Stem Cells. J Medical Case Repo, 4(1), 1-3. DOI:

https://doi.org/10.47485/2767-5416

Nalisa, D.L. (2022). Stem Cell Therapy for Diabetic Foot Ulcers: Theory and Practice. J Diabetes Res, 6;2022:6028743. https://doi.org/10.1155/2022/6028743.

Kubiak, C. (2020). Stem-cell-based therapies to enhance peripheral nerve regeneration. Muscle Nerve, 61(4), 449-459. doi: https://doi.org/10.1002/mus.26760

Hamad, A., & Alhiti, H. A. (2022). Stem Cell Therapy Modulates Cerebral Palsy: Case Report. J. Archives of Medical Case Reports and Case Study, 5(3), 118-122. https://doi.org/10.31579/2692-9392/118

Hamad, A., & Alhiti, H. A. (2023). Stem Cells and Nanosilver Saved Diabetic Foot. Journal of Liaquat University of Medical & Health Sciences, 21(5), 20-23. DOI: https://doi.org/10.22442/jlumhs.2023.00991

Røikjer J. (2021). Diabetic Peripheral Neuropathy: Diagnosis and Treatment. Curr Drug Saf, 16(1), 2-16. https://doi.org/10.2174/1574886315666200731173113

Jensen T. (2021). Painful and non-painful diabetic neuropathy, diagnostic challenges and implications for future management. Brain, 28, 144(6), 1632-1645. doi: https://doi.org/10.1093/brain/awab079

Staff N. (2020). Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systems. Exp Neurol, 324, 113121. doi: https://doi.org/10.1016/j.expneurol.2019.113121

Pantazis C. (2020). A reference human induced pluripotent stem cell line for large-scale collaborative studies. Cell Stem Cell, 29(12), 1685-1702.e22.doi: https://doi.org/10.1016/j.stem.2022.11.004.

Hamad, A., & Alhiti, H. A. (2021). Baghdad's first success in Bone Marrow Aspirate Concentrate procedure. Journal of Oran Faculty of Medicine, 5(2), 695-700. https://doi.org/10.51782/jfmo.v5i2.126

Lopes B. (2021). Peripheral Nerve Injury Treatments and Advances: One Health Perspective. Int J Mol Sci, 23(2), 918. doi: https://doi.org/10.3390/ijms23020918

Seghieri G. (2023). Metrics of Gender Differences in Mortality Risk after Diabetic Foot Disease. J Clin Med, 12(9), 3288. doi: https://doi.org/10.3390/jcm12093288

Downloads

Published

15-09-2024

How to Cite

Alhiti, D. H. A. R., & Dr. Ahmad Mansour Hamad. (2024). Stem Cells Rehabilitate Diabetic Neuropathy. International Innovations Journal of Applied Science, 1(2). https://doi.org/10.61856/7c8pf105

Similar Articles

You may also start an advanced similarity search for this article.